Volume 8, Issue 3 , Pages 297-302.e1, March 2010
Associations Among Behavior-Related Susceptibility Factors in Porphyria Cutanea Tarda
Background & Aims
Porphyria cutanea tarda (PCT) is the most common of the human porphyrias and results from an acquired deficiency of hepatic uroporphyrinogen decarboxylase (UROD). Some susceptibility factors have been identified; we examined associations among multiple factors in a large cohort of patients.
Methods
Multiple known or suspected susceptibility factors and demographic and clinical features of 143 patients (mean age 52 years, 66% male, 88% Caucasian) with documented PCT (mean onset at 41 ± 8.8 years) were tabulated; associations were examined by contingency tables, classification and regression tree (CART) analysis, and logistic regression.
Results
The most common susceptibility factors for PCT were ethanol use (87%), smoking (81%), chronic hepatitis C virus (HCV) infection (69%), and HFE mutations (53%; 6% C282Y/C282Y and 8% C282Y/H63D). Of those who underwent hepatic biopsy or ultrasound, 56% had evidence of hepatic steatosis. Of those with PCT, 66% of females took estrogen, 8% were diabetic, 13% had human immunodeficiency virus (HIV) infection, and 17% had inherited uroporphyrinogen decarboxylase (UROD) deficiency (determined by low erythrocyte UROD activity). Three or more susceptibility factors were identified in 70% of patients. HCV infection in patients with PCT was significantly associated with other behavior-related factors such as ethanol use (odds ratio [OR], 6.3) and smoking (OR, 11.9).
Conclusions
Susceptibility factors for PCT were similar to previous studies; most patients had 3 or more susceptibility factors. Associations between PCT and HCV, ethanol or smoking could be accounted for by a history of multiple substance abuse; other factors are distributed more randomly among patients.
Keywords: Porphyria, Hepatitis C, Alcohol
Abbreviations used in this paper: CART, classification and regression tree, HCV, hepatitis C virus, HIV, human immunodeficiency virus, OR, odds ratio, PCT, porphyria cutanea tarda, UROD, uroporphyrinogen decarboxylase, UTMB, University of Texas Medical Branch.
Conflict of interest The authors disclose no conflicts.
Funding Grant support: This study was supported in part by grants R21 DK073093 from the National Institutes of Health, R01 FD002604 from the US Food and Drug Administration Office of Rare Diseases and a General Clinical Research Center grant MO1-RR000073 from the National Center for Research Resources of the National Institutes of Health.
PII: S1542-3565(09)01218-X
doi:10.1016/j.cgh.2009.11.017
© 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
Volume 8, Issue 3 , Pages 297-302.e1, March 2010


